Functional characterization of CYP2D7 gene variants

Pharmacogenomics. 2018 Aug 1;19(12):931-936. doi: 10.2217/pgs-2018-0065. Epub 2018 Jul 24.

Abstract

The ultrarapid CYP2D6 metabolizer (UM) phenotype is caused by CYP2D6 gene duplications in some, but not all, UM individuals. CYP2D6 and the adjacent pseudogene CYP2D7 are highly homologous; however, CYP2D7 harbors a premature stop codon, which is absent in carriers of the rare CYP2D7 variant rs530303678. We addressed whether rs530303678 could generate a functionally active protein, causing the UM phenotype. However, unlike CYP2D6 variants, two CYP2D7 rs530303678 variant isoforms, previously described in liver, showed neither significant protein expression nor catalytic activity toward the CYP2D6 substrates bufuralol or dextromethorphan. We conclude that loss of the stop codon in CYP2D7 does not result in the generation of enzymatically active protein in human liver and thus, cannot cause the UM phenotype.

Keywords: CYP2D6; CYP2D7; bufuralol; dextromethorphan; ultrarapid metabolizam.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cell Line
  • Cytochrome P-450 Enzyme System / genetics*
  • Genetic Variation / genetics*
  • Humans
  • Liver / enzymology

Substances

  • Cytochrome P-450 Enzyme System
  • CYP2D7 protein, human